Clinical Studies
Published Clinical Studies
View and download clinical studies to stay up-to-date and educated on the efficacy of Nobivac vaccines.
Antibodies Induced by Repeated Borrella Burgdorferi Vaccine Administration are Not Detected in Vise-Derived C6 Peptide
Stillman, Thacher, Beall, Goldstein, Lappin, O’Conner, Chandrashekar
Introduction
Introduction of Lyme disease vaccines for use in canines has led to the widespread use of vaccine in Lyme disease-endemic areas of the United States. The SNAP 4Dx Plus Test Kit uses 8orrelia-specific peptide (C6 peptide) for detection of antibody to 8orrelia burgdorferi. Numerous published scientific articles have documented that those immunoassays incorporating the C6 peptide as the target diagnostic antigen failed to react with sera from vaccinated dogs. The purpose of the study was to test sera from vaccinated dogs using the CG-peptide-based microtiter format ELISA and SNAP 4Dx Plus test to demonstrate that these tests are non-reactive with samples from dogs receiving repeated vaccinations.
Bacterin That Induces Anti-OspA and Anti-OspC Borreliacidal Antibodies Provides a High Level of Protection Against Canine Lyme Disease
Rhonda L. LaFleur, Jennifer C. Dant, Terri L. Wasmoen, Steven M. Callister, Dean A Jobe, Steven D. Lovrich, Thomas F. Warner, 0. Abdelmagid, and Ronald F. Schell
Introduction
Canine Infectious Respiratory Disease Complex
Leah A. Cohn, DVM, PhD, DACVIM
Introduction
Comparative Efficacy of Feline Leukemia Virus Inactivated Whole Virus Vaccine and Canarypox Virus-Vectored Vaccine by Modern Molecular Assays and Conventional Parameters
M. Patel, K. Carritt, J. Lane, H. Jayappa, M. Stahl
Introduction
Comparison of the Mucosal Immune Response in Dogs Vaccinated with Either an Intranasal Avirulent Live Culture or a Subcutaneous Antigen Extract Vaccine of Bordetella bronchiseptica
Randy Davis, BS, Huchappa Jayappa, MVSc, PhD, Omar Y. Abdelmagid, BVSc, MS, PhD, Rob Armstrong, DVM, DVSc, Diane Sweeney, PhD, Craig Lehr, BS
Introduction
Comparitive Efficacy of Feline Leukemia Virus Inactivated Whole Virus Vaccine and Canarypox Virus-Vectored Vaccine by Molecular Assays and Conventional Parameters
M. Patel, K. Carritt, J. Lane, H. Jayappa, M. Stahl
Introduction
Demonstration of 1-Year Duration of Immunity for Attenuated Bordetella bronchiseptica Vaccines in Dogs
Craig Lehr, BS, Huchappa Jayappa, MVSc, PhD, Jason Erskine, BS, Alicia Brown, BS, Diane Sweeney, PhD, Terri Wasmoen, PhD
Introduction
Diagnosing and Managing Canine Leptospirosis: IDEXX Reference Laboratories Introduces a RealPCR™ Test for Canine Leptospirosis
IDEXX Reference Laboratories
Introduction
Disease & Mortality Study
Read the study which proves high efficacy of Nobivac® Lepto₄ vaccine under severe challenge.
Introduction
Efficacy of an Inactivated FeLV Vaccine Compared to a Recombinant FeLV Vaccine in Minimum Age Cats Following Virulent FeLV Challenge
Kristin Stuke, Vickie King, Kendra Southwick, Mira I. Stoeva, Anne Thomas, M. Teresa C. Winkler
Introduction
Feline Leukaemia Virus: a Review of Immunity and Vaccination
A. H. Sparkes
Introduction
Feline Leukemia Virus Immunity Induced by Whole Inactivated Virus Vaccination
Andrea N. Torres, Kevin P. O’Halloran, Laurie J. Larson, Ronald D. Schultz, Edward A. Hoover
Introduction
lmmunogenicity and Efficacy of a Commercial Feline Leukemia Virus Vaccine
Niels C. Pedersen, DVM, PhD
Introduction
One-Year Duration of Immunity Induced by Vaccination with a Canine Lyme Disease Bacterin
Rhonda L. LaFleur, Steven M. Callister, Jennifer C. Dant, Dean A. Jobe, Steven D. Lovrich, Thomas F. Warner, Terri L. Wasmoen, and Ronald F. Schell
Introduction
Prevalance of Canine Infectious Respiritory Disease Complex Pathogens in Dogs in the Chicago Region (March-April 2015)
Jill A. Richardson, Amy Glaser, Nyssa Reine-Salz, Edward J. Dubovi
Introduction
